Arthropod vector-borne uveitis in the developing world

International Ophthalmology Clinics

Volumn 50, Issue 2, 2010, Pages 125-144

  Khairallah, Moncef ^a   Yahia, Salim Ben ^a   Attia, Sonia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHLORAMPHENICOL; CHLOROQUINE; CLARITHROMYCIN; CYCLOPLEGIC AGENT; DOXYCYCLINE; IMMUNOGLOBULIN; INTERFERON; JOSAMYCIN; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; STEROID; TETRACYCLINE; VASCULOTROPIN ANTIBODY;

AFRICAN TRYPANOSOMIASIS; ARTHROPOD VECTOR BORNE DISEASE; ASSISTED VENTILATION; BANCROFTIAN FILARIASIS; BED REST; BLOOD TRANSFUSION; BORRELIA INFECTION; BOUTONNEUSE FEVER; BUNYAVIRUS; CAT SCRATCH DISEASE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CILIARY DISK; CLINICAL TRIAL; CONJUNCTIVITIS; DENGUE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; EYE DISEASE; EYE EXAMINATION; FEVER; FLAVIVIRUS; GEOGRAPHIC DISTRIBUTION; HEMORRHAGIC FEVER; HUMAN; INFECTION; INTRAOCULAR HYPERTENSION; INTRAVENOUS ADMINISTRATION; IRIDOCYCLITIS; KERATITIS; LASER COAGULATION; LOIASIS; LYME DISEASE; MALARIA; MYIASIS; NONHUMAN; ONCHOCERCIASIS; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; OPTIC NEURITIS; PARASITE VECTOR; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; Q FEVER; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SCRUB TYPHUS; SUBRETINAL NEOVASCULARIZATION; TRENCH FEVER; TYPHUS; UVEITIS; VIRUS INFECTION; VIRUS TRANSMISSION; VITRECTOMY; VITREOUS HEMORRHAGE; VITRITIS; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION; YAWS; YELLOW FEVER;

ANIMALS; ARTHROPOD VECTORS; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; EYE INFECTIONS; HUMANS; INCIDENCE; UVEITIS;

EID: 77951085276     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181d2cf2e     Document Type: Review

References (72)

1. Alio J, Ruiz-Beltran R, Herrero-Herrero J, et al. Retinal manifestations of Mediterranean spotted fever. Ophthalmologica. 1987;195:31-37. (Pubitemid 17136490)
2. Khairallah M, Ladjimi A, Chakroun M, et al. Posterior segment manifestations of Rickettsia conorii infection. Ophthalmology. 2004;111:529-534.
3. Duffey RJ, Hammer ME. The ocular manifestations of Rocky Mountain spotted fever. Ann Ophthalmol. 1987;19:301-306.
4. Hudson HL, Thach AB, Lopez PF. Retinal manifestations of acute murine typhus. Int Ophthalmol. 1997;21:121-126.
5. Nagaki Y, Hayasaka S, Kadoi C, et al. Branch retinal vein occlusion in the right eye and retinal hemorrhage in the left eye in a patient with classic Tsutsugamushi disease. Jpn J Ophthalmol. 2001;45:108-110.
6. Ormerod LD, Skolnick KA, Menosky MM, et al. Retinal and choroidal manifestations of cat-scratch disease. Ophthalmology. 1998;105:1024-1031.
7. Roe RH, Michael Jumper J, Fu AD, et al. Ocular bartonella infections. Int Ophthalmol Clin. 2008;48:93-105.
8. Golnik KC, Marotto ME, Fanous MM, et al. Ophthalmic manifestations of Rochalimaea species. Am J Ophthalmol. 1994;118:145-151.
9. Ruiz-Moreno JM. Choroidal neovascularization in the course of Q fever. Retina. 1997;17:553-555.
10. Kuhne F, Morlat P, Riss I, et al. Is A29, B12 vasculitis caused by the Q fever agent? (Coxiella burnetii). J Fr Ophtalmol. 1992;15:315-321.
11. Karma A, Seppälä I, Mikkilä H, et al. Diagnosis and clinical charachteristics of ocular lyme borreliosis. Am J Ophthalmol. 1995;119:127-135.
12. Lim LL, Rosenbaum JT. Borrelia hermsii causing relapsing Fever and uveitis. Am J Ophthalmol. 2006;142:348-349.
13. Sarangapani S, Benjamin L. Posterior segment changes secondary to late yaws. Eye. 2001;15:664-666.
14. Khairallah M, Ben Yahia S, Ladjimi A, et al. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology. 2004;111:2065-2070.
15. Garg S, Jampol LM. Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol. 2005;50:3-13.
16. Chan CK, Limstrom SA, Tarasewicz DG, et al. Ocular features of west nile virus infection in North America: a study of 14 eyes. Ophthalmology. 2006;113: 1539-1546.
17. Al-Hazmi A, Al-Rajhi AA, Abboud EB, et al. Ocular complications of rift valley fever outbreak in Saudi Arabia. Ophthalmology. 2005;112:313-318.
18. Lim WK, Mathur R, Koh A, et al. Ocular manifestations of dengue. Ophthalmology. 2004;111:2057-2064.
19. Bacsal K, Chee SP, Cheng CL, et al. Dengue-associated maculopathy. Arch Ophthalmol. 2007;125:501-510.
20. Laurence B, Harold M, Thierry D. Ocular complications of dengue fever. Ophthalmology. 2008;115:1100-1101.
21. Digoutte JP. Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever. Rift Valley fever Bull Soc Pathol Exot. 1999;92:343-348.
22. Mahendradas P, Ranganna S, Shetty R. Ocular manifestations associated with Chikungunya. Ophthalmology. 2008;115:287-291.
23. Lalitha P, Rathinam S, Banushree K, et al. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144: 552-556.
24. Nayak AJ, Srinivasa Rao PN. Ocular changes in Kyasanur forest disease. J Indian Med Assoc. 1983;81:158-160.
25. Mehta SA, Ansari AS, Jiandani P. Opthalmoscopic findings in adult patients with severe falciparum malaria. Ocul Immunol Inflamm. 2008;16:239-241.
26. Buissonniére RF, De Boissieu D, Tell G, et al. Uveo-meningitis revealing a West African trypanosomiasis in a 12-year-old girl. Arch Fr Pediatr. 1989;46:517-519.
27. Newland HS, White AT, Greene BM, et al. Ocular manifestations of onchocerciasis in a rain forest area of west Africa. Br J Ophthalmol. 1991;75:163-169.
28. Semba RD, Murphy RP, Newland HS, et al. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology. 1990;97:1334-1341.
29. Toufic N. Loaiasis and its ocular impact in Central Africa. Bull Soc Ophtalmol Fr. 1985;85:1175-1180.
30. Bainbridge J, Rostron C. External ocular myiasis due to Oestrus ovis in a tourist returning from North Africa. Eye. 1998;12:897-898.
31. Ganesh SK, Babu K, Krishnakumar S, et al. Ocular filariasis due to Wuchereria bancrofti presenting as panuveitis: a case report. Ocul Immunol Inflamm. 2003;11: 145-148.
32. Rao NG, Mahapatra SK, Pattnayak S, et al. Intravitreal live adult Brugian filariasis. Indian J Ophthalmol. 2008;56:76-78.
33. Parola P, Raoult D. Rickettsioses éruptives. EMC (Elsevier Paris) Maladies infectieuses. 1998; 24p. (8-037-I-20)
34. Mc Dade JE. Rickettsial diseases. In: Hausler WJ, Sussman M, eds. Topley and Wilson's Microbilogy and Microbial Infections. 9th ed. Vol.3. London: Arnold; 1998:995-1011.
35. Adan A, Lopez-Sorra A, Moser C, et al. Use of steroids and heparin to treat retinal arterial occlusion in mediterranean spotted fever. J Infect Dis. 1998;158: 1139-1140.
36. Han SB, Kim JH, Kim SJ, et al. Diagnostic and therapeutic challenges. Retina. 2008;28:1166-1169.
37. Khairallah M, Ben Yahia S, Zaouali S. Rickettsioses. In: Gupta A, Gupta V, Herbort C, et al, eds. Uveitis, Text and Imaging. Jaypee: 2009:687-693.
38. Khairallah M, Zaouali S, Ben Yahia S, et al. Anterior ischemic optic neuropathy associated with rickettsia conorii infection. J Neuroophthalmol. 2005;25:212-214.
39. Vaphiades MS. Rocky mountain spotted fever as a cause of macular star figure. J Neuroophthalmol. 2003;23:276-278.
40. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179.
41. Seth RK, Stoessel KM, Adelman RA. Choroidal neovascularization associated with West Nile virus chorioretinitis. Semin Ophthalmol. 2007;22:81-84.
42. Kuchtey RW, Kosmorsky G, Martin D, et al. Uveitis associated with West Nile virus infection. Arch Ophthalmol. 2003;121:1648-1649.
43. Kaiser PK, Lee MS, Martin DA. Occlusive vasculitis in a patient with concomitantWest Nile virus infection. Am J Ophthalmol. 2003;136:928-930.
44. Khairallah M, Ben Yahia S, Attia S, et al. Severe ischemic maculopathy in a patient with West Nile virus infection. Ophthalmic Surg Lasers Imaging. 2006;37:240-242. (Pubitemid 43886121)
45. Gilad R, Lampl Y, Sadeh M, et al. Optic neuritis complicating West Nile virus meningitis in a young adult. Infection. 2003;31:55-56.
46. Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol. 2003;136:733-735.
47. Khairallah M, Ben Yahia S, Attia S, et al. Linear pattern of West Nile virus-associated chorioretinitis is related to retinal nerve fibres organization. Eye. 2007;21:952-955.
48. Khairallah M, Ben Yahia S, Attia S, et al. Indocyanine green angiographic features in multifocal chorioretinitis associated with West Nile virus infection. Retina. 2006;26: 358-359.
49. Khairallah M, Ben Yahia S, Letaief M, et al. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus Infection. Ocular Immunology and Inflammation. 2007;15:435-439.
50. Abroug F, Ouanes-Besbes L, Letaief M, et al. A cluster study of predictors of severe West Nile virus infection. Mayo Clin Proc. 2006;81:12-16. (Pubitemid 43054312)
51. Anninger W, Lubow M. Visual loss with West Nile virus infection: a wider spectrum of a ''new'' disease. Clin Infect Dis. 2004;38:e55-e56.
52. Jordan I, Briese N, Fischer N, et al. Ribavirin inhibits West Nile virus replication and cytopathic effect in neutral cells. J Infect Dis. 2000;182:1214-1217.
53. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79:13350-13361.
54. Gea-Banacloche J, Johnson RT, Bagic A, et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med. 2004;140:545-553.
55. Ellis DS, Simpson DI, Stamford S, et al. Rift Valley fever virus: some ultrastructural observations on material from outbreak in Egypt 1977. J Gen Virol. 1979;42:329-337.
56. Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J Pathol Bacteriol 1931;34:545-579.
57. Meegan JM, Watten RH, Laughlin LW. Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic. Contrib Epidemiol Biostatics. 1981;3: 114-123.
58. Siam AL, Meegan JM, Gharbawi KF. Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt. Br J Ophthalmol. 1980;64: 366-374.
59. Olaleye OD, Tomori O, Ladipo MA, et al. Rift Valley fever in Nigeria: infections in humans. Revue Scientifique et Technique. 1996;15:923-935.
60. Garcia LL, Crance JM, Billecocq A, et al. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. Journal of Clinical Microbiology. 2001;39:4456-4461.
61. Peters CJ. Bunyaviridae. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Disease. 5th ed. Philadelphia: Churchill Livingstone; 2000: 1849-1855.
62. Halstead SB. Dengue. Curr Opinion Infect Dis. 2001;15:471-476.
63. Kapoor HK, Bhai S, John M, et al. Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol. 2006;41:741-746.
64. Cruz-Villegas V, Berrocal AM, Davis JL. Bilateral choroidal effusions associated with dengue fever. Retina. 2003;23:576-578.
65. Calisher CH, Shope RE, Brandt W, et al. Proposed antigenic classification of registered arboviruses I (Togaviridae, Alphavirus). Intervirology. 1980;14:229-232.
66. Economopoulou A, Dominguez M, Helynck A, et al. Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2008;11:1-8.
67. Mittal A, Mittal S, Bharathi JM, et al. Uveitis during outbreak of chikungunya fever. Ophthalmology. 2007;114:1798.
68. Murthy KR, Venkataraman N, Satish V, et al. Bilateral retinitis following chikungunya fever. Indian J Opthalmol. 2008;56:329-331.
69. Mittal A, Mittal S, Bharati MJ, et al. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381-1386.
70. Rohani A, Yulfi H, Zamree I, et al. Rapid detection of chikungunya virus in laboratory infected Aedes aegypti by reverse-transcriptase-polymerase chain reaction (RT-PCR). Trop Biomed. 2005;22:149-154.
71. Brighton SW. Chloroquine phosphate treatment of chronic chikungunya arthritis. An open pilot study. S Afr Med J. 1984;66:217-218.
72. Elston DM. Prevention of arthropod-related disease. J Am Acad Dermatol. 2004; 51:947-954.